• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Dis (Lond) . Genetic diversity and impact of vaccination on influenza A (H1N1)pdm09 in Mar del Plata, Argentina: a 2015-2020 molecular epidem

tetano

Editor, Senior Moderator
Infect Dis (Lond)


. 2025 Feb 21:1-14.
doi: 10.1080/23744235.2025.2466118. Online ahead of print. Genetic diversity and impact of vaccination on influenza A (H1N1)pdm09 in Mar del Plata, Argentina: a 2015-2020 molecular epidemiological study

Osvaldo Uez[SUP] 1 2 [/SUP], Andrés Culasso[SUP] 3 4 [/SUP], Andrea Lerman[SUP] 1 2 [/SUP], Carlos Cimmino[SUP] 1 2 [/SUP], Rodolfo Campos[SUP] 3 4 [/SUP], Débora Natalia Marcone[SUP] 3 4 5 [/SUP]



Affiliations
Abstract

Background: Influenza A viruses are a major cause of viral respiratory infections in humans, leading to a spectrum of diseases ranging from mild to severe, particularly in high-risk groups. Monitoring the frequency and evolution of A (H1N1)pdm09 viruses is essential for guiding vaccine strain selection and maintaining vaccine effectiveness.
Objectives: To characterize the evolution of circulating influenza A (H1N1)pdm09 strains in Mar del Plata(MDQ), Argentina, and estimate vaccine efficacy from 2015 to 2020, before the SARS-CoV-2 pandemic.
Methods: We analyzed 46 influenza A (H1N1)pdm09 strains detected by RT-PCR from patients with acute respiratory infections in MDQ between 2015 and 2020. Phylogenetic analysis was performed using maximum likelihood, and vaccine efficacy was estimated with the P[SUB]epitope[/SUB] model.
Results: Seven genetic clades were identified: 6B in 2015, 6B.1 in 2016-2017, 6B.1A, 6B.1A.1, and 6B.1A.3 in 2018, 6B.1A.5A in 2019-2020, and 6B.1A.5a.2 in 2020. Genetic diversity and regional clustering suggested multiple strain introductions from other Argentinian regions or countries. The predicted vaccine efficacy was highest when the frequency of influenza A (H1N1)pmd09 was below 2%, decreasing as viral frequency increased, due to mutations occurring particularly in haemagglutinin epitopes B, C, and E.
Conclusion: Our findings highlight the dynamic evolution of influenza A (H1N1)pdm09 in MDQ and emphasize the importance of continuous molecular surveillance and regular vaccine updates. Additionally, the P[SUB]epitope[/SUB] model proved useful in estimating vaccine efficacy. The impact of vaccination in reducing viral frequency when circulating and vaccine strains are well-matched further supports annual influenza vaccination recommendations to minimize viral burden in the community.

Keywords: Influenza virus; antigenic distance; clades; genetic group; haemagglutinin; phylogeny.

 
Back
Top Bottom